Research ArticleClinical Studies

High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III

HIROAKI NOZAWA, KAZUSHIGE KAWAI, KEISUKE HATA, TOSHIAKI TANAKA, TAKESHI NISHIKAWA, KENSUKE OTANI, KAZUHITO SASAKI, MANABU KANEKO, SHIGENOBU EMOTO and KOJI MURONO
In Vivo September 2018, 32 (5) 1235-1240; DOI: https://doi.org/10.21873/invivo.11370

Article Information

vol. 32 no. 5 1235-1240
DOI 
https://doi.org/10.21873/invivo.11370
PMID 
30150450
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received February 25, 2018
  • Revision received May 30, 2018
  • Accepted June 4, 2018
  • Published online August 27, 2018.
Copyright & License 
Copyright © 2018 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. HIROAKI NOZAWA⇑,
  2. KAZUSHIGE KAWAI,
  3. KEISUKE HATA,
  4. TOSHIAKI TANAKA,
  5. TAKESHI NISHIKAWA,
  6. KENSUKE OTANI,
  7. KAZUHITO SASAKI,
  8. MANABU KANEKO,
  9. SHIGENOBU EMOTO and
  10. KOJI MURONO
  1. Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  1. Correspondence to: Hiroaki Nozawa, MD, PhD, Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Tel: +81 358008653, Fax: +81 338116822, e-mail: hiroanozawa-gi{at}umin.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III
HIROAKI NOZAWA, KAZUSHIGE KAWAI, KEISUKE HATA, TOSHIAKI TANAKA, TAKESHI NISHIKAWA, KENSUKE OTANI, KAZUHITO SASAKI, MANABU KANEKO, SHIGENOBU EMOTO, KOJI MURONO
In Vivo Sep 2018, 32 (5) 1235-1240; DOI: 10.21873/invivo.11370
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords